nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—osteoarthritis—Prednisone—psoriatic arthritis	0.267	0.5	CpDpCtD
Meloxicam—osteoarthritis—Methylprednisolone—psoriatic arthritis	0.267	0.5	CpDpCtD
Meloxicam—PGD—Methotrexate—psoriatic arthritis	0.134	0.354	CbGbCtD
Meloxicam—PTGS2—Triamcinolone—psoriatic arthritis	0.0544	0.143	CbGbCtD
Meloxicam—PTGS2—Betamethasone—psoriatic arthritis	0.0466	0.123	CbGbCtD
Meloxicam—ABCC4—Methotrexate—psoriatic arthritis	0.0371	0.0978	CbGbCtD
Meloxicam—PTGS2—Dexamethasone—psoriatic arthritis	0.0271	0.0715	CbGbCtD
Meloxicam—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0142	0.0374	CbGbCtD
Meloxicam—CYP2C8—Dexamethasone—psoriatic arthritis	0.0132	0.0349	CbGbCtD
Meloxicam—CYP3A4—Triamcinolone—psoriatic arthritis	0.0107	0.0283	CbGbCtD
Meloxicam—CYP2C9—Dexamethasone—psoriatic arthritis	0.00922	0.0243	CbGbCtD
Meloxicam—CYP3A4—Betamethasone—psoriatic arthritis	0.00922	0.0243	CbGbCtD
Meloxicam—CYP3A4—Prednisolone—psoriatic arthritis	0.0091	0.024	CbGbCtD
Meloxicam—CYP3A4—Prednisone—psoriatic arthritis	0.00859	0.0226	CbGbCtD
Meloxicam—CYP3A4—Dexamethasone—psoriatic arthritis	0.00536	0.0141	CbGbCtD
Meloxicam—PTGS2—Fluocinonide—Methylprednisolone—psoriatic arthritis	0.000455	0.159	CbGdCrCtD
Meloxicam—PTGS2—Fluocinonide—Betamethasone—psoriatic arthritis	0.000448	0.156	CbGdCrCtD
Meloxicam—PTGS2—Fluocinonide—Dexamethasone—psoriatic arthritis	0.000448	0.156	CbGdCrCtD
Meloxicam—PTGS2—Fluocinonide—Triamcinolone—psoriatic arthritis	0.000438	0.153	CbGdCrCtD
Meloxicam—PTGS2—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.000275	0.0957	CbGdCrCtD
Meloxicam—PTGS2—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.000271	0.0942	CbGdCrCtD
Meloxicam—PTGS2—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.000271	0.0942	CbGdCrCtD
Meloxicam—PTGS2—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.000264	0.0921	CbGdCrCtD
Meloxicam—Infection—Methylprednisolone—psoriatic arthritis	0.000106	0.00126	CcSEcCtD
Meloxicam—Haematuria—Methotrexate—psoriatic arthritis	0.000106	0.00125	CcSEcCtD
Meloxicam—Shock—Triamcinolone—psoriatic arthritis	0.000105	0.00125	CcSEcCtD
Meloxicam—Insomnia—Prednisolone—psoriatic arthritis	0.000105	0.00125	CcSEcCtD
Meloxicam—Alopecia—Prednisone—psoriatic arthritis	0.000105	0.00125	CcSEcCtD
Meloxicam—Shock—Methylprednisolone—psoriatic arthritis	0.000105	0.00125	CcSEcCtD
Meloxicam—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000105	0.00124	CcSEcCtD
Meloxicam—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000105	0.00124	CcSEcCtD
Meloxicam—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000105	0.00124	CcSEcCtD
Meloxicam—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000105	0.00124	CcSEcCtD
Meloxicam—Paraesthesia—Prednisolone—psoriatic arthritis	0.000105	0.00124	CcSEcCtD
Meloxicam—Tachycardia—Triamcinolone—psoriatic arthritis	0.000104	0.00124	CcSEcCtD
Meloxicam—Mental disorder—Prednisone—psoriatic arthritis	0.000104	0.00124	CcSEcCtD
Meloxicam—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000104	0.00124	CcSEcCtD
Meloxicam—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000104	0.00123	CcSEcCtD
Meloxicam—Erythema—Prednisone—psoriatic arthritis	0.000104	0.00123	CcSEcCtD
Meloxicam—Malnutrition—Prednisone—psoriatic arthritis	0.000104	0.00123	CcSEcCtD
Meloxicam—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000103	0.00123	CcSEcCtD
Meloxicam—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000103	0.00123	CcSEcCtD
Meloxicam—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000103	0.00123	CcSEcCtD
Meloxicam—Convulsion—Dexamethasone—psoriatic arthritis	0.000103	0.00122	CcSEcCtD
Meloxicam—Convulsion—Betamethasone—psoriatic arthritis	0.000103	0.00122	CcSEcCtD
Meloxicam—Hypertension—Dexamethasone—psoriatic arthritis	0.000103	0.00122	CcSEcCtD
Meloxicam—Hypertension—Betamethasone—psoriatic arthritis	0.000103	0.00122	CcSEcCtD
Meloxicam—Myalgia—Dexamethasone—psoriatic arthritis	0.000101	0.0012	CcSEcCtD
Meloxicam—Myalgia—Betamethasone—psoriatic arthritis	0.000101	0.0012	CcSEcCtD
Meloxicam—Anxiety—Dexamethasone—psoriatic arthritis	0.000101	0.0012	CcSEcCtD
Meloxicam—Anxiety—Betamethasone—psoriatic arthritis	0.000101	0.0012	CcSEcCtD
Meloxicam—Discomfort—Dexamethasone—psoriatic arthritis	0.0001	0.00119	CcSEcCtD
Meloxicam—Discomfort—Betamethasone—psoriatic arthritis	0.0001	0.00119	CcSEcCtD
Meloxicam—Haemoglobin—Methotrexate—psoriatic arthritis	0.0001	0.00119	CcSEcCtD
Meloxicam—Hypotension—Methylprednisolone—psoriatic arthritis	9.98e-05	0.00118	CcSEcCtD
Meloxicam—Pain—Prednisolone—psoriatic arthritis	9.95e-05	0.00118	CcSEcCtD
Meloxicam—Hepatitis—Methotrexate—psoriatic arthritis	9.95e-05	0.00118	CcSEcCtD
Meloxicam—Haemorrhage—Methotrexate—psoriatic arthritis	9.95e-05	0.00118	CcSEcCtD
Meloxicam—Pharyngitis—Methotrexate—psoriatic arthritis	9.87e-05	0.00117	CcSEcCtD
Meloxicam—Urinary tract disorder—Methotrexate—psoriatic arthritis	9.83e-05	0.00117	CcSEcCtD
Meloxicam—Vision blurred—Prednisone—psoriatic arthritis	9.77e-05	0.00116	CcSEcCtD
Meloxicam—Urethral disorder—Methotrexate—psoriatic arthritis	9.75e-05	0.00116	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	9.75e-05	0.00116	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	9.73e-05	0.00116	CcSEcCtD
Meloxicam—Oedema—Dexamethasone—psoriatic arthritis	9.71e-05	0.00115	CcSEcCtD
Meloxicam—Oedema—Betamethasone—psoriatic arthritis	9.71e-05	0.00115	CcSEcCtD
Meloxicam—Anaphylactic shock—Dexamethasone—psoriatic arthritis	9.71e-05	0.00115	CcSEcCtD
Meloxicam—Anaphylactic shock—Betamethasone—psoriatic arthritis	9.71e-05	0.00115	CcSEcCtD
Meloxicam—Insomnia—Triamcinolone—psoriatic arthritis	9.68e-05	0.00115	CcSEcCtD
Meloxicam—Insomnia—Methylprednisolone—psoriatic arthritis	9.66e-05	0.00115	CcSEcCtD
Meloxicam—Infection—Dexamethasone—psoriatic arthritis	9.65e-05	0.00115	CcSEcCtD
Meloxicam—Infection—Betamethasone—psoriatic arthritis	9.65e-05	0.00115	CcSEcCtD
Meloxicam—Ill-defined disorder—Prednisone—psoriatic arthritis	9.62e-05	0.00114	CcSEcCtD
Meloxicam—Paraesthesia—Triamcinolone—psoriatic arthritis	9.61e-05	0.00114	CcSEcCtD
Meloxicam—Feeling abnormal—Prednisolone—psoriatic arthritis	9.59e-05	0.00114	CcSEcCtD
Meloxicam—Paraesthesia—Methylprednisolone—psoriatic arthritis	9.59e-05	0.00114	CcSEcCtD
Meloxicam—Visual impairment—Methotrexate—psoriatic arthritis	9.59e-05	0.00114	CcSEcCtD
Meloxicam—Anaemia—Prednisone—psoriatic arthritis	9.58e-05	0.00114	CcSEcCtD
Meloxicam—Shock—Betamethasone—psoriatic arthritis	9.55e-05	0.00113	CcSEcCtD
Meloxicam—Shock—Dexamethasone—psoriatic arthritis	9.55e-05	0.00113	CcSEcCtD
Meloxicam—Dyspnoea—Triamcinolone—psoriatic arthritis	9.54e-05	0.00113	CcSEcCtD
Meloxicam—Nervous system disorder—Betamethasone—psoriatic arthritis	9.52e-05	0.00113	CcSEcCtD
Meloxicam—Nervous system disorder—Dexamethasone—psoriatic arthritis	9.52e-05	0.00113	CcSEcCtD
Meloxicam—Thrombocytopenia—Dexamethasone—psoriatic arthritis	9.51e-05	0.00113	CcSEcCtD
Meloxicam—Thrombocytopenia—Betamethasone—psoriatic arthritis	9.51e-05	0.00113	CcSEcCtD
Meloxicam—Tachycardia—Dexamethasone—psoriatic arthritis	9.48e-05	0.00113	CcSEcCtD
Meloxicam—Tachycardia—Betamethasone—psoriatic arthritis	9.48e-05	0.00113	CcSEcCtD
Meloxicam—Angioedema—Prednisone—psoriatic arthritis	9.47e-05	0.00112	CcSEcCtD
Meloxicam—Dyspepsia—Triamcinolone—psoriatic arthritis	9.42e-05	0.00112	CcSEcCtD
Meloxicam—Erythema multiforme—Methotrexate—psoriatic arthritis	9.41e-05	0.00112	CcSEcCtD
Meloxicam—Dyspepsia—Methylprednisolone—psoriatic arthritis	9.4e-05	0.00112	CcSEcCtD
Meloxicam—Hyperhidrosis—Betamethasone—psoriatic arthritis	9.39e-05	0.00111	CcSEcCtD
Meloxicam—Hyperhidrosis—Dexamethasone—psoriatic arthritis	9.39e-05	0.00111	CcSEcCtD
Meloxicam—Malaise—Prednisone—psoriatic arthritis	9.35e-05	0.00111	CcSEcCtD
Meloxicam—Vertigo—Prednisone—psoriatic arthritis	9.31e-05	0.00111	CcSEcCtD
Meloxicam—Eye disorder—Methotrexate—psoriatic arthritis	9.3e-05	0.0011	CcSEcCtD
Meloxicam—Syncope—Prednisone—psoriatic arthritis	9.29e-05	0.0011	CcSEcCtD
Meloxicam—Tinnitus—Methotrexate—psoriatic arthritis	9.28e-05	0.0011	CcSEcCtD
Meloxicam—Urticaria—Prednisolone—psoriatic arthritis	9.25e-05	0.0011	CcSEcCtD
Meloxicam—Cardiac disorder—Methotrexate—psoriatic arthritis	9.23e-05	0.0011	CcSEcCtD
Meloxicam—Fatigue—Triamcinolone—psoriatic arthritis	9.23e-05	0.0011	CcSEcCtD
Meloxicam—Fatigue—Methylprednisolone—psoriatic arthritis	9.21e-05	0.00109	CcSEcCtD
Meloxicam—Pain—Triamcinolone—psoriatic arthritis	9.15e-05	0.00109	CcSEcCtD
Meloxicam—Loss of consciousness—Prednisone—psoriatic arthritis	9.11e-05	0.00108	CcSEcCtD
Meloxicam—Hypotension—Dexamethasone—psoriatic arthritis	9.07e-05	0.00108	CcSEcCtD
Meloxicam—Hypotension—Betamethasone—psoriatic arthritis	9.07e-05	0.00108	CcSEcCtD
Meloxicam—Angiopathy—Methotrexate—psoriatic arthritis	9.03e-05	0.00107	CcSEcCtD
Meloxicam—Immune system disorder—Methotrexate—psoriatic arthritis	8.99e-05	0.00107	CcSEcCtD
Meloxicam—Convulsion—Prednisone—psoriatic arthritis	8.98e-05	0.00107	CcSEcCtD
Meloxicam—Mediastinal disorder—Methotrexate—psoriatic arthritis	8.97e-05	0.00106	CcSEcCtD
Meloxicam—Hypertension—Prednisone—psoriatic arthritis	8.95e-05	0.00106	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	8.85e-05	0.00105	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	8.85e-05	0.00105	CcSEcCtD
Meloxicam—Arthralgia—Prednisone—psoriatic arthritis	8.82e-05	0.00105	CcSEcCtD
Meloxicam—Myalgia—Prednisone—psoriatic arthritis	8.82e-05	0.00105	CcSEcCtD
Meloxicam—Feeling abnormal—Triamcinolone—psoriatic arthritis	8.82e-05	0.00105	CcSEcCtD
Meloxicam—Feeling abnormal—Methylprednisolone—psoriatic arthritis	8.8e-05	0.00104	CcSEcCtD
Meloxicam—Anxiety—Prednisone—psoriatic arthritis	8.79e-05	0.00104	CcSEcCtD
Meloxicam—Alopecia—Methotrexate—psoriatic arthritis	8.79e-05	0.00104	CcSEcCtD
Meloxicam—Insomnia—Dexamethasone—psoriatic arthritis	8.78e-05	0.00104	CcSEcCtD
Meloxicam—Insomnia—Betamethasone—psoriatic arthritis	8.78e-05	0.00104	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	8.76e-05	0.00104	CcSEcCtD
Meloxicam—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	8.73e-05	0.00104	CcSEcCtD
Meloxicam—Paraesthesia—Betamethasone—psoriatic arthritis	8.72e-05	0.00104	CcSEcCtD
Meloxicam—Paraesthesia—Dexamethasone—psoriatic arthritis	8.72e-05	0.00104	CcSEcCtD
Meloxicam—Discomfort—Prednisone—psoriatic arthritis	8.72e-05	0.00103	CcSEcCtD
Meloxicam—Mental disorder—Methotrexate—psoriatic arthritis	8.72e-05	0.00103	CcSEcCtD
Meloxicam—Erythema—Methotrexate—psoriatic arthritis	8.66e-05	0.00103	CcSEcCtD
Meloxicam—Malnutrition—Methotrexate—psoriatic arthritis	8.66e-05	0.00103	CcSEcCtD
Meloxicam—Hypersensitivity—Prednisolone—psoriatic arthritis	8.58e-05	0.00102	CcSEcCtD
Meloxicam—Dyspepsia—Dexamethasone—psoriatic arthritis	8.55e-05	0.00101	CcSEcCtD
Meloxicam—Dyspepsia—Betamethasone—psoriatic arthritis	8.55e-05	0.00101	CcSEcCtD
Meloxicam—Urticaria—Triamcinolone—psoriatic arthritis	8.5e-05	0.00101	CcSEcCtD
Meloxicam—Urticaria—Methylprednisolone—psoriatic arthritis	8.48e-05	0.00101	CcSEcCtD
Meloxicam—Dysgeusia—Methotrexate—psoriatic arthritis	8.48e-05	0.00101	CcSEcCtD
Meloxicam—Body temperature increased—Triamcinolone—psoriatic arthritis	8.46e-05	0.001	CcSEcCtD
Meloxicam—Oedema—Prednisone—psoriatic arthritis	8.46e-05	0.001	CcSEcCtD
Meloxicam—Anaphylactic shock—Prednisone—psoriatic arthritis	8.46e-05	0.001	CcSEcCtD
Meloxicam—Abdominal pain—Methylprednisolone—psoriatic arthritis	8.44e-05	0.001	CcSEcCtD
Meloxicam—Decreased appetite—Betamethasone—psoriatic arthritis	8.44e-05	0.001	CcSEcCtD
Meloxicam—Decreased appetite—Dexamethasone—psoriatic arthritis	8.44e-05	0.001	CcSEcCtD
Meloxicam—Infection—Prednisone—psoriatic arthritis	8.4e-05	0.000998	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	8.38e-05	0.000995	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	8.38e-05	0.000995	CcSEcCtD
Meloxicam—Back pain—Methotrexate—psoriatic arthritis	8.38e-05	0.000995	CcSEcCtD
Meloxicam—Fatigue—Dexamethasone—psoriatic arthritis	8.37e-05	0.000994	CcSEcCtD
Meloxicam—Fatigue—Betamethasone—psoriatic arthritis	8.37e-05	0.000994	CcSEcCtD
Meloxicam—Shock—Prednisone—psoriatic arthritis	8.32e-05	0.000988	CcSEcCtD
Meloxicam—Pain—Dexamethasone—psoriatic arthritis	8.3e-05	0.000986	CcSEcCtD
Meloxicam—Pain—Betamethasone—psoriatic arthritis	8.3e-05	0.000986	CcSEcCtD
Meloxicam—Nervous system disorder—Prednisone—psoriatic arthritis	8.29e-05	0.000985	CcSEcCtD
Meloxicam—Tachycardia—Prednisone—psoriatic arthritis	8.25e-05	0.00098	CcSEcCtD
Meloxicam—Skin disorder—Prednisone—psoriatic arthritis	8.22e-05	0.000975	CcSEcCtD
Meloxicam—Hyperhidrosis—Prednisone—psoriatic arthritis	8.18e-05	0.000971	CcSEcCtD
Meloxicam—Vision blurred—Methotrexate—psoriatic arthritis	8.16e-05	0.000969	CcSEcCtD
Meloxicam—Ill-defined disorder—Methotrexate—psoriatic arthritis	8.04e-05	0.000954	CcSEcCtD
Meloxicam—Anaemia—Methotrexate—psoriatic arthritis	8e-05	0.00095	CcSEcCtD
Meloxicam—Feeling abnormal—Dexamethasone—psoriatic arthritis	8e-05	0.00095	CcSEcCtD
Meloxicam—Feeling abnormal—Betamethasone—psoriatic arthritis	8e-05	0.00095	CcSEcCtD
Meloxicam—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	7.94e-05	0.000943	CcSEcCtD
Meloxicam—Gastrointestinal pain—Betamethasone—psoriatic arthritis	7.94e-05	0.000943	CcSEcCtD
Meloxicam—Hypersensitivity—Triamcinolone—psoriatic arthritis	7.89e-05	0.000936	CcSEcCtD
Meloxicam—Hypersensitivity—Methylprednisolone—psoriatic arthritis	7.87e-05	0.000934	CcSEcCtD
Meloxicam—Malaise—Methotrexate—psoriatic arthritis	7.81e-05	0.000927	CcSEcCtD
Meloxicam—Vertigo—Methotrexate—psoriatic arthritis	7.78e-05	0.000924	CcSEcCtD
Meloxicam—Leukopenia—Methotrexate—psoriatic arthritis	7.75e-05	0.00092	CcSEcCtD
Meloxicam—Urticaria—Betamethasone—psoriatic arthritis	7.72e-05	0.000916	CcSEcCtD
Meloxicam—Urticaria—Dexamethasone—psoriatic arthritis	7.72e-05	0.000916	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	7.71e-05	0.000915	CcSEcCtD
Meloxicam—Dizziness—Prednisolone—psoriatic arthritis	7.7e-05	0.000914	CcSEcCtD
Meloxicam—Asthenia—Triamcinolone—psoriatic arthritis	7.68e-05	0.000912	CcSEcCtD
Meloxicam—Abdominal pain—Betamethasone—psoriatic arthritis	7.68e-05	0.000912	CcSEcCtD
Meloxicam—Abdominal pain—Dexamethasone—psoriatic arthritis	7.68e-05	0.000912	CcSEcCtD
Meloxicam—Body temperature increased—Betamethasone—psoriatic arthritis	7.68e-05	0.000912	CcSEcCtD
Meloxicam—Body temperature increased—Dexamethasone—psoriatic arthritis	7.68e-05	0.000912	CcSEcCtD
Meloxicam—Asthenia—Methylprednisolone—psoriatic arthritis	7.66e-05	0.00091	CcSEcCtD
Meloxicam—Insomnia—Prednisone—psoriatic arthritis	7.65e-05	0.000908	CcSEcCtD
Meloxicam—Paraesthesia—Prednisone—psoriatic arthritis	7.59e-05	0.000902	CcSEcCtD
Meloxicam—Pruritus—Triamcinolone—psoriatic arthritis	7.57e-05	0.000899	CcSEcCtD
Meloxicam—Cough—Methotrexate—psoriatic arthritis	7.56e-05	0.000897	CcSEcCtD
Meloxicam—Pruritus—Methylprednisolone—psoriatic arthritis	7.56e-05	0.000897	CcSEcCtD
Meloxicam—Convulsion—Methotrexate—psoriatic arthritis	7.5e-05	0.000891	CcSEcCtD
Meloxicam—Dyspepsia—Prednisone—psoriatic arthritis	7.44e-05	0.000884	CcSEcCtD
Meloxicam—Arthralgia—Methotrexate—psoriatic arthritis	7.37e-05	0.000875	CcSEcCtD
Meloxicam—Myalgia—Methotrexate—psoriatic arthritis	7.37e-05	0.000875	CcSEcCtD
Meloxicam—Decreased appetite—Prednisone—psoriatic arthritis	7.35e-05	0.000873	CcSEcCtD
Meloxicam—Rash—Prednisolone—psoriatic arthritis	7.34e-05	0.000871	CcSEcCtD
Meloxicam—Dermatitis—Prednisolone—psoriatic arthritis	7.33e-05	0.00087	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	7.32e-05	0.000869	CcSEcCtD
Meloxicam—Diarrhoea—Methylprednisolone—psoriatic arthritis	7.31e-05	0.000868	CcSEcCtD
Meloxicam—Fatigue—Prednisone—psoriatic arthritis	7.29e-05	0.000866	CcSEcCtD
Meloxicam—Headache—Prednisolone—psoriatic arthritis	7.29e-05	0.000866	CcSEcCtD
Meloxicam—Discomfort—Methotrexate—psoriatic arthritis	7.29e-05	0.000865	CcSEcCtD
Meloxicam—Constipation—Prednisone—psoriatic arthritis	7.23e-05	0.000859	CcSEcCtD
Meloxicam—Confusional state—Methotrexate—psoriatic arthritis	7.13e-05	0.000846	CcSEcCtD
Meloxicam—Dizziness—Triamcinolone—psoriatic arthritis	7.08e-05	0.00084	CcSEcCtD
Meloxicam—Anaphylactic shock—Methotrexate—psoriatic arthritis	7.07e-05	0.000839	CcSEcCtD
Meloxicam—Dizziness—Methylprednisolone—psoriatic arthritis	7.06e-05	0.000838	CcSEcCtD
Meloxicam—Infection—Methotrexate—psoriatic arthritis	7.02e-05	0.000834	CcSEcCtD
Meloxicam—Feeling abnormal—Prednisone—psoriatic arthritis	6.97e-05	0.000827	CcSEcCtD
Meloxicam—Asthenia—Dexamethasone—psoriatic arthritis	6.97e-05	0.000827	CcSEcCtD
Meloxicam—Asthenia—Betamethasone—psoriatic arthritis	6.97e-05	0.000827	CcSEcCtD
Meloxicam—Nervous system disorder—Methotrexate—psoriatic arthritis	6.93e-05	0.000823	CcSEcCtD
Meloxicam—Thrombocytopenia—Methotrexate—psoriatic arthritis	6.92e-05	0.000822	CcSEcCtD
Meloxicam—Gastrointestinal pain—Prednisone—psoriatic arthritis	6.92e-05	0.000821	CcSEcCtD
Meloxicam—Nausea—Prednisolone—psoriatic arthritis	6.91e-05	0.000821	CcSEcCtD
Meloxicam—Pruritus—Dexamethasone—psoriatic arthritis	6.87e-05	0.000816	CcSEcCtD
Meloxicam—Pruritus—Betamethasone—psoriatic arthritis	6.87e-05	0.000816	CcSEcCtD
Meloxicam—Skin disorder—Methotrexate—psoriatic arthritis	6.87e-05	0.000815	CcSEcCtD
Meloxicam—Hyperhidrosis—Methotrexate—psoriatic arthritis	6.83e-05	0.000811	CcSEcCtD
Meloxicam—Vomiting—Triamcinolone—psoriatic arthritis	6.81e-05	0.000808	CcSEcCtD
Meloxicam—Vomiting—Methylprednisolone—psoriatic arthritis	6.79e-05	0.000806	CcSEcCtD
Meloxicam—Rash—Triamcinolone—psoriatic arthritis	6.75e-05	0.000801	CcSEcCtD
Meloxicam—Dermatitis—Triamcinolone—psoriatic arthritis	6.74e-05	0.000801	CcSEcCtD
Meloxicam—Rash—Methylprednisolone—psoriatic arthritis	6.73e-05	0.000799	CcSEcCtD
Meloxicam—Dermatitis—Methylprednisolone—psoriatic arthritis	6.73e-05	0.000799	CcSEcCtD
Meloxicam—Urticaria—Prednisone—psoriatic arthritis	6.72e-05	0.000798	CcSEcCtD
Meloxicam—Headache—Triamcinolone—psoriatic arthritis	6.71e-05	0.000796	CcSEcCtD
Meloxicam—Headache—Methylprednisolone—psoriatic arthritis	6.69e-05	0.000794	CcSEcCtD
Meloxicam—Body temperature increased—Prednisone—psoriatic arthritis	6.69e-05	0.000794	CcSEcCtD
Meloxicam—Abdominal pain—Prednisone—psoriatic arthritis	6.69e-05	0.000794	CcSEcCtD
Meloxicam—Diarrhoea—Betamethasone—psoriatic arthritis	6.64e-05	0.000789	CcSEcCtD
Meloxicam—Diarrhoea—Dexamethasone—psoriatic arthritis	6.64e-05	0.000789	CcSEcCtD
Meloxicam—Hypotension—Methotrexate—psoriatic arthritis	6.6e-05	0.000784	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	6.44e-05	0.000765	CcSEcCtD
Meloxicam—Dizziness—Betamethasone—psoriatic arthritis	6.42e-05	0.000762	CcSEcCtD
Meloxicam—Dizziness—Dexamethasone—psoriatic arthritis	6.42e-05	0.000762	CcSEcCtD
Meloxicam—Insomnia—Methotrexate—psoriatic arthritis	6.39e-05	0.000759	CcSEcCtD
Meloxicam—Nausea—Triamcinolone—psoriatic arthritis	6.36e-05	0.000755	CcSEcCtD
Meloxicam—Paraesthesia—Methotrexate—psoriatic arthritis	6.35e-05	0.000754	CcSEcCtD
Meloxicam—Nausea—Methylprednisolone—psoriatic arthritis	6.34e-05	0.000753	CcSEcCtD
Meloxicam—Dyspnoea—Methotrexate—psoriatic arthritis	6.3e-05	0.000748	CcSEcCtD
Meloxicam—Somnolence—Methotrexate—psoriatic arthritis	6.28e-05	0.000746	CcSEcCtD
Meloxicam—Hypersensitivity—Prednisone—psoriatic arthritis	6.23e-05	0.00074	CcSEcCtD
Meloxicam—Dyspepsia—Methotrexate—psoriatic arthritis	6.22e-05	0.000739	CcSEcCtD
Meloxicam—Vomiting—Betamethasone—psoriatic arthritis	6.17e-05	0.000733	CcSEcCtD
Meloxicam—Vomiting—Dexamethasone—psoriatic arthritis	6.17e-05	0.000733	CcSEcCtD
Meloxicam—Decreased appetite—Methotrexate—psoriatic arthritis	6.14e-05	0.00073	CcSEcCtD
Meloxicam—Rash—Dexamethasone—psoriatic arthritis	6.12e-05	0.000727	CcSEcCtD
Meloxicam—Rash—Betamethasone—psoriatic arthritis	6.12e-05	0.000727	CcSEcCtD
Meloxicam—Dermatitis—Dexamethasone—psoriatic arthritis	6.12e-05	0.000726	CcSEcCtD
Meloxicam—Dermatitis—Betamethasone—psoriatic arthritis	6.12e-05	0.000726	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	6.1e-05	0.000725	CcSEcCtD
Meloxicam—Fatigue—Methotrexate—psoriatic arthritis	6.09e-05	0.000724	CcSEcCtD
Meloxicam—Headache—Betamethasone—psoriatic arthritis	6.08e-05	0.000722	CcSEcCtD
Meloxicam—Headache—Dexamethasone—psoriatic arthritis	6.08e-05	0.000722	CcSEcCtD
Meloxicam—Asthenia—Prednisone—psoriatic arthritis	6.07e-05	0.00072	CcSEcCtD
Meloxicam—Pain—Methotrexate—psoriatic arthritis	6.04e-05	0.000718	CcSEcCtD
Meloxicam—Pruritus—Prednisone—psoriatic arthritis	5.98e-05	0.00071	CcSEcCtD
Meloxicam—Feeling abnormal—Methotrexate—psoriatic arthritis	5.82e-05	0.000692	CcSEcCtD
Meloxicam—Diarrhoea—Prednisone—psoriatic arthritis	5.79e-05	0.000687	CcSEcCtD
Meloxicam—Gastrointestinal pain—Methotrexate—psoriatic arthritis	5.78e-05	0.000686	CcSEcCtD
Meloxicam—Nausea—Dexamethasone—psoriatic arthritis	5.77e-05	0.000685	CcSEcCtD
Meloxicam—Nausea—Betamethasone—psoriatic arthritis	5.77e-05	0.000685	CcSEcCtD
Meloxicam—Urticaria—Methotrexate—psoriatic arthritis	5.62e-05	0.000667	CcSEcCtD
Meloxicam—Dizziness—Prednisone—psoriatic arthritis	5.59e-05	0.000664	CcSEcCtD
Meloxicam—Abdominal pain—Methotrexate—psoriatic arthritis	5.59e-05	0.000663	CcSEcCtD
Meloxicam—Body temperature increased—Methotrexate—psoriatic arthritis	5.59e-05	0.000663	CcSEcCtD
Meloxicam—Vomiting—Prednisone—psoriatic arthritis	5.38e-05	0.000638	CcSEcCtD
Meloxicam—Rash—Prednisone—psoriatic arthritis	5.33e-05	0.000633	CcSEcCtD
Meloxicam—Dermatitis—Prednisone—psoriatic arthritis	5.33e-05	0.000633	CcSEcCtD
Meloxicam—Headache—Prednisone—psoriatic arthritis	5.3e-05	0.000629	CcSEcCtD
Meloxicam—Hypersensitivity—Methotrexate—psoriatic arthritis	5.21e-05	0.000618	CcSEcCtD
Meloxicam—Asthenia—Methotrexate—psoriatic arthritis	5.07e-05	0.000602	CcSEcCtD
Meloxicam—Nausea—Prednisone—psoriatic arthritis	5.02e-05	0.000596	CcSEcCtD
Meloxicam—Pruritus—Methotrexate—psoriatic arthritis	5e-05	0.000594	CcSEcCtD
Meloxicam—Diarrhoea—Methotrexate—psoriatic arthritis	4.84e-05	0.000574	CcSEcCtD
Meloxicam—Dizziness—Methotrexate—psoriatic arthritis	4.67e-05	0.000555	CcSEcCtD
Meloxicam—Vomiting—Methotrexate—psoriatic arthritis	4.49e-05	0.000534	CcSEcCtD
Meloxicam—Rash—Methotrexate—psoriatic arthritis	4.46e-05	0.000529	CcSEcCtD
Meloxicam—Dermatitis—Methotrexate—psoriatic arthritis	4.45e-05	0.000529	CcSEcCtD
Meloxicam—Headache—Methotrexate—psoriatic arthritis	4.43e-05	0.000526	CcSEcCtD
Meloxicam—Nausea—Methotrexate—psoriatic arthritis	4.2e-05	0.000498	CcSEcCtD
